Assertio holdings, inc. to acquire spectrum pharmaceuticals, inc. in all stock and cvr transaction

Complementary commercial growth platforms anticipated to accelerate rolvedon™ (eflapegrastim-xnst) injection profitability and diversify revenue streams

ASRT Ratings Summary

ASRT Quant Ranking